Inhibition by arabinosylcytosine of DNA synthesis in bone marrows of relapsed AML patients.
D000328:Adult; D000368:Aged; D001853:Bone Marrow / Q000187:drug effects / Q000378:metabolism*; D002470:Cell Survival / Q000187:drug effects; D003561:Cytarabine / Q000494:pharmacology* / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D013936:Thymidine / Q000378:metabolism
D004273:DNA, Neoplasm; D003561:Cytarabine; D013936:Thymidine